A

Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408

Watchlist Manager
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Watchlist
Price: 12.64 CNY -5.81% Market Closed
Market Cap: 5.1B CNY
Have any thoughts about
Anhui Huaren Health Pharmaceutical Co Ltd?
Write Note

Net Margin
Anhui Huaren Health Pharmaceutical Co Ltd

3.3%
Current
4%
Average
1.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.3%
=
Net Income
133m
/
Revenue
4.1B

Net Margin Across Competitors

Country CN
Market Cap 5.1B CNY
Net Margin
3%
Country ZA
Market Cap 94.9B Zac
Net Margin
6%
Country ZA
Market Cap 33.4B Zac
Net Margin
3%
Country US
Market Cap 7.7B USD
Net Margin
-6%
Country BR
Market Cap 44.1B BRL
Net Margin
3%
Country JP
Market Cap 862.9B JPY
Net Margin
5%
Country SA
Market Cap 16.8B SAR
Net Margin
9%
Country CN
Market Cap 30.3B CNY
Net Margin
6%
Country MX
Market Cap 81.1B MXN
Net Margin
4%
Country JP
Market Cap 556B JPY
Net Margin
3%
Country NL
Market Cap 3.2B EUR
Net Margin
0%

Profitability Report

View the profitability report to see the full profitability analysis for Anhui Huaren Health Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.3%
=
Net Income
133m
/
Revenue
4.1B
What is the Net Margin of Anhui Huaren Health Pharmaceutical Co Ltd?

Based on Anhui Huaren Health Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 3.3%.